TARDBP and amyotrophic lateral sclerosis: Finally, as we detail further in the next section (Section 3: TARDBP/TDP-43 Autonomous/Non-autonomous Regulation), some mutations identified in ALS patients by Luquin and colleagues [172] in the promoter region of TARDBP promoter have been tested in different cell lines without significant effect on its activity in the tested conditions [173].